Skip to main content
Clinical Trials/ACTRN12610001022055
ACTRN12610001022055
Recruiting
Phase 4

For patients with ureteral stent insertion after ureteroscopic stone manipulations, is Solifenacin effective in relieving ureteral stent-related symptoms?

Mennonite Christian Hospital, Taiwan0 sites100 target enrollmentNovember 22, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
reteral stent-related symptoms after ureteroscopic stone manipulation.
Sponsor
Mennonite Christian Hospital, Taiwan
Enrollment
100
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 22, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mennonite Christian Hospital, Taiwan

Eligibility Criteria

Inclusion Criteria

  • From 01/10/2010 to 30/10/2011, all patients with unilateral ureteral stones to be treated with ureteroscopy where temporary stenting is indicated will be considered for enrollment in the study.

Exclusion Criteria

  • Patients who had significant ureteral trauma, a preexisting ureteral stent, another secondary surgical procedure that would have impacted patient comfort, ie transurethral resection of the prostate or of bladder tumor, or urinary infection or chronic pain history will be excluded from study.

Outcomes

Primary Outcomes

Not specified

Similar Trials